weight loss first week tirzepatide What to Expect: in the Weight loss results after 8
Description
Across multiple phase III trials, tirzepatide has consistently produced greater reductions in glycated hemoglobin and body weight compared with established GLP 1 receptor agonists and other standard therapies

It may be particularly helpful for people who: Have type 2 diabetes with excess weight or insulin resistance Have inadequate control on metformin or other oral therapies Want to minimise hypoglycaemia risk Wish to delay or reduce insulin requirements As with all diabetes therapies, Mounjaro works best when combined with sustainable changes in eating patterns, activity, sleep, and long-term support themes we explore in depth across our education programs and webinars

Percentages were calculated using year-end reported financial results from Merck for 2021 and AbbVie for 2022

What is tirzepatide injection

Its meant to be used alongside healthy eating and exercise
